z-logo
open-access-imgOpen Access
Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
Author(s) -
Dan Shingo,
Shirakawa Mieko,
Mukai Yumiko,
Yoshida Yoko,
Yamazaki Kanami,
Kawaguchi Tokuichi,
Matsuura Masaaki,
Nakamura Yusuke,
Yamori Takao
Publication year - 2003
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2003.tb01403.x
Subject(s) - gene , cell culture , cancer cell lines , gene expression , cancer , biology , cancer research , computational biology , medicine , genetics , cancer cell
We previously investigated the correlations between the expression of 9216 genes and various chemosensitivities in a panel of 39 human cancer cell lines 1) and found that the expression levels of AKR1B1 and CTSH were correlated with sensitivity and resistance to multiple drugs, respectively. To validate these correlations, we investigated the expression of these two genes and the chemosensitivities in 12 additional gastric cancer cell lines. The expression of AKR1B1 in the additional cell lines exhibited significant correlations with sensitivities to 8 of the 23 drugs examined, while that of CTSH displayed a significant negative correlation with only one (MS‐247) of the 27 drugs examined. Their expressions were weakly correlated with sensitivity and resistance, respectively, to the remainder of the drugs. Moreover, when the 12 cell lines were divided into high‐expressing and low‐expressing groups, a comparison of these groups using Mann‐Whitney's U test revealed that high expression levels of AKR1B1 and CTSH were related to sensitivity to 21 of the drugs and resistance to 8 of the drugs, respectively. The present results suggest that AKR1B1 and CTSH may be good markers for prediction of sensitivity to certain drugs and that our panel of 39 cell lines has the potential to identify candidate predictive marker genes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here